期刊文献+

肺癌多学科综合治疗面临的挑战和机遇 被引量:7

原文传递
导出
摘要 经过近50多年的努力,目前肺癌的治疗已具有规范化和循证化的特点,建立在循证医学证据基础上的肺癌诊断治疗指南是其重要的标志,如中国抗癌协会肺癌专业委员会制定的《中国肺癌诊断治疗指引》和美国的《国家癌症综合网络(NCCN)肺癌指引中国版》,这两个指南的最大特点是以临床分期为基础的肺癌多学科综合治疗,也就是肺癌的规范化分期治疗模式。
作者 吴一龙
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2007年第2期81-82,共2页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献10

  • 1吴一龙.肺癌多学科综合治疗的理论基础[A].吴一龙主编.肺癌多学科综合治疗的理论和实践[C].北京:人民卫生出版社,2000.1-17.
  • 2Greenlee RT,Murray T,Bolden S,et al.Cancer Statistics,2000.CA Cancer J Clini,2000,50:7-33.
  • 3Auperin A,Le Pechoux C,Pignon JP,et al.Concomitant radiochemotherapy based on platin compounds in patients with locally advanced non-samll cell lung cancer (NSCLC):a meta-analysis of individual data from 1764 patients.Ann Oncol,2006,17:473-483.
  • 4Potti A,Mukherjee S,Petersen R,et al.A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.N Engl J Med,2006,355:570-580.
  • 5Lynch TJ,Bell DW,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.N Engl J Med,2004,350:2129-2139.
  • 6Paez JG,Janne PA,Lee JC,et al.EGFR mutations in lung cancer:correlation with clinical response to gefitinib therapy.Science,2004,304:1497-1500.
  • 7Qiao GB,Wu YL,Yang XN,et al.High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients.Br J Cancer,2005,93:137-143.
  • 8Wu YL,Lin JY,Wang K,et al.EGFR mutations in lung cancers and sensitivity to gefitinib in Chinese.J Clin Oncol,2005,23:61s.
  • 9吴一龙,林嘉颖,杨学宁,乔贵宾,王坤,陈刚.肺腺癌患者酪氨酸激酶信号传导通路的异常与临床预后[J].中华医学杂志,2004,84(12):992-996. 被引量:9
  • 10吴一龙,杨衿记,林嘉颖,黄玉娟,廖日强,黄逸生,周清,徐崇锐,王震.吉非替尼靶向治疗非小细胞肺癌的临床研究[J].中华结核和呼吸杂志,2007,30(2):98-102. 被引量:49

二级参考文献14

  • 1吴一龙.肺癌分子靶向治疗的个体化[J].循证医学,2004,4(2):67-68. 被引量:9
  • 2张晓彤,李龙芸,王树兰,穆新林,王孟昭.吉非替尼治疗晚期非小细胞肺癌疗效观察[J].中华结核和呼吸杂志,2005,28(3):180-183. 被引量:31
  • 3管忠震,张力,李龙芸,蒋国梁,刘叙仪,储大同,赵洪云,李玮.吉非替尼治疗局部晚期或转移性非小细胞肺癌在中国的临床研究[J].癌症,2005,24(8):980-984. 被引量:114
  • 4韩宝惠.肺癌分子靶向治疗的现状与挑战[J].中华结核和呼吸杂志,2007,30(2):83-85. 被引量:13
  • 5Lilly MB, Zemskova M, Frankel AE, et al. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor subunit mediate activation of Jak/Stat signaling and differentiation. Blood, 2001, 97: 1662-1670.
  • 6Zhu CH, Domann FE. Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth. Breast Cancer Res Treat, 2002, 71: 47-57.
  • 7Weng G, Bhalla US, Iyengar R. Complexity in biological signaling systems. Science, 1999, 284:92-96.
  • 8徐宁志.信号传导与肿瘤[A].见:曾益新主编.肿瘤学[M]:第2版[C].北京:人民卫生出版社,2003.128-147.
  • 9吴一龙,廖美琳,蒋国梁,等.临床诊治指南—肿瘤学分册.北京:人民卫生出版社,2005:96-135.
  • 10Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92:205-216.

共引文献63

同被引文献81

引证文献7

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部